STAAR Surgical Reports Fourth Quarter and Full Year 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
STAAR Surgical (STAA) Tops Q4 EPS by 9c
February 26, 2020 4:14 PM ESTSTAAR Surgical (NASDAQ: STAA) reported Q4 EPS of $0.12, $0.09 better than the analyst estimate of $0.03. Revenue for the quarter came in at $38.9 million versus the consensus estimate of $38.42 million.
Fourth Quarter 2019 Overview
Net Sales of $38.9 Million Up 25% from the Prior Year QuarterICL Sales of $33.3 Million Up 27% and Units Up 27% from the Prior Year QuarterGross Margin at 74.1% vs. 73.7% in the Prior Year QuarterNet Income of $0.14 per Share vs. Prior Year Quarter Net Income of $0.02 per ShareNet Income includes a $0.07 per Share tax benefit above the previously announced preliminary... More